EMEA-002571-PIP01-19

Table of contents

Key facts

Active substance
Adeno-associated viral vector serotype 8 containing the human MTM1 gene (resamirigene bilparvovec)
Therapeutic area
Other
Decision number
P/0309/2020
PIP number
EMEA-002571-PIP01-19
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of X linked myotubular myopathy
Route(s) of administration
Intravenous use
Contact for public enquiries
Audentes Therapeutics Inc

E-mail: info@audentestx.com
Tel: +1 4158181001

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating